Clinical Trial Update: Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating renin-angiotensin system blockade in renal transplant patients with urinary PECs (Chronic Kidney Allograft Nephropathy).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Allograft Nephropathy

Snippet

Sponsor: Josep M Cruzado | Conditions: Chronic Kidney Allograft Nephropathy | Phase 4 | Status: UNKNOWN